As foundational AI models muscle into biosciences and pharmaceuticals, what does it mean for India's $55-billion ...

Intensifying pipeline competition and shorter differentiation windows demand faster, higher-precision launch decisions as most products fail to reach “international excellence” and many generate ...

Behavior Labs, a new life sciences intelligence company, today launched a platform that gives pharmaceutical and medical ...

The arrival of cheaper semaglutide alternatives signals that the Indian obesity drug market has moved from a launch-led boom into something more structurally competitive ...

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Gilead Sciences agreed to acquire Tubulis GmbH for upwards of $5 billion in a deal that significantly expands Gilead's oncology pipeline and establishes Munich as a dedicated antibody-drug conjugates ...

Zentiva is focused on the development, manufacturing and supply of generic, branded specialty and over-the-counter medicines and products, serving more than 100 million people across over 40 countries ...

JINAN CITY, SHANDONG PROVINCE, CHINA, April 8, 2026 /EINPresswire.com/ -- The packaging industry has been going through ...

Eli Lilly (LLY) stock drops after FDA approves Foundayo oral GLP-1 drug for obesity, intensifying competition and highlighting side effect concerns.

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease productsAggregate consideration of USD250,000,000 (approximately ...

Motilal Oswal is reshaping its FY26 strategy—betting on SBI, Jio Financial and domestic growth plays as crude risks and ...